SGIOF
Price
$19.00
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
Capitalization
15.06B
TEVJF
Price
$20.01
Change
+$5.69 (+39.73%)
Updated
Sep 25 closing price
Capitalization
21.75B
Interact to see
Advertisement

SGIOF vs TEVJF

Header iconSGIOF vs TEVJF Comparison
Open Charts SGIOF vs TEVJFBanner chart's image
Shionogi & Co
Price$19.00
Change-$0.00 (-0.00%)
Volume$500
Capitalization15.06B
Teva Pharmaceutical Industries
Price$20.01
Change+$5.69 (+39.73%)
Volume$100
Capitalization21.75B
SGIOF vs TEVJF Comparison Chart in %
Loading...
SGIOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TEVJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SGIOF vs. TEVJF commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SGIOF is a Buy and TEVJF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (SGIOF: $19.00 vs. TEVJF: $20.01)
Brand notoriety: SGIOF and TEVJF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: SGIOF: 133% vs. TEVJF: 93%
Market capitalization -- SGIOF: $15.06B vs. TEVJF: $21.75B
SGIOF [@Pharmaceuticals: Generic] is valued at $15.06B. TEVJF’s [@Pharmaceuticals: Generic] market capitalization is $21.75B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SGIOF’s FA Score shows that 2 FA rating(s) are green whileTEVJF’s FA Score has 1 green FA rating(s).

  • SGIOF’s FA Score: 2 green, 3 red.
  • TEVJF’s FA Score: 1 green, 4 red.
According to our system of comparison, SGIOF is a better buy in the long-term than TEVJF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SGIOF’s TA Score shows that 3 TA indicator(s) are bullish while TEVJF’s TA Score has 4 bullish TA indicator(s).

  • SGIOF’s TA Score: 3 bullish, 2 bearish.
  • TEVJF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, TEVJF is a better buy in the short-term than SGIOF.

Price Growth

SGIOF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while TEVJF (@Pharmaceuticals: Generic) price change was +39.73% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.88%. For the same industry, the average monthly price growth was +23.85%, and the average quarterly price growth was +67.10%.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.88% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TEVJF($21.7B) has a higher market cap than SGIOF($15.1B). SGIOF YTD gains are higher at: 55.610 vs. TEVJF (8.162). SGIOF has higher annual earnings (EBITDA): 206B vs. TEVJF (1.9B). SGIOF has more cash in the bank: 576B vs. TEVJF (2.16B). SGIOF has less debt than TEVJF: SGIOF (11.7B) vs TEVJF (17.5B). SGIOF has higher revenues than TEVJF: SGIOF (419B) vs TEVJF (16.6B).
SGIOFTEVJFSGIOF / TEVJF
Capitalization15.1B21.7B70%
EBITDA206B1.9B10,848%
Gain YTD55.6108.162681%
P/E Ratio14.00N/A-
Revenue419B16.6B2,524%
Total Cash576B2.16B26,654%
Total Debt11.7B17.5B67%
FUNDAMENTALS RATINGS
SGIOF vs TEVJF: Fundamental Ratings
SGIOF
TEVJF
OUTLOOK RATING
1..100
4744
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
76
Overvalued
PROFIT vs RISK RATING
1..100
9737
SMR RATING
1..100
292
PRICE GROWTH RATING
1..100
4779
P/E GROWTH RATING
1..100
3413
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SGIOF's Valuation (25) in the null industry is somewhat better than the same rating for TEVJF (76). This means that SGIOF’s stock grew somewhat faster than TEVJF’s over the last 12 months.

TEVJF's Profit vs Risk Rating (37) in the null industry is somewhat better than the same rating for SGIOF (97). This means that TEVJF’s stock grew somewhat faster than SGIOF’s over the last 12 months.

SGIOF's SMR Rating (2) in the null industry is significantly better than the same rating for TEVJF (92). This means that SGIOF’s stock grew significantly faster than TEVJF’s over the last 12 months.

SGIOF's Price Growth Rating (47) in the null industry is in the same range as TEVJF (79). This means that SGIOF’s stock grew similarly to TEVJF’s over the last 12 months.

TEVJF's P/E Growth Rating (13) in the null industry is in the same range as SGIOF (34). This means that TEVJF’s stock grew similarly to SGIOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SGIOFTEVJF
RSI
ODDS (%)
Bearish Trend 1 day ago
48%
Bearish Trend 1 day ago
69%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
48%
Bullish Trend 1 day ago
55%
Momentum
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 3 days ago
58%
MACD
ODDS (%)
Bearish Trend 1 day ago
48%
Bullish Trend 1 day ago
56%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
45%
Bullish Trend 1 day ago
55%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 1 day ago
48%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
41%
Bearish Trend 1 day ago
43%
View a ticker or compare two or three
Interact to see
Advertisement
SGIOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TEVJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QQQM244.33-1.06
-0.43%
Invesco NASDAQ 100 ETF
DIM76.14-0.47
-0.61%
WisdomTree International MidCap Div ETF
PDT13.23-0.11
-0.82%
John Hancock Premium Dividend Fund
CBTA31.63-0.74
-2.28%
Calamos Bitcoin 80 Series Structured Alt Protection ETF - April
WANT51.17-2.09
-3.92%
Direxion Daily Cnsmr Discret Bull 3X ETF

SGIOF and

Correlation & Price change

A.I.dvisor tells us that SGIOF and AGYTF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SGIOF and AGYTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOF
1D Price
Change %
SGIOF100%
N/A
AGYTF - SGIOF
25%
Poorly correlated
N/A
HLNCF - SGIOF
21%
Poorly correlated
+0.90%
SFOSF - SGIOF
11%
Poorly correlated
N/A
ROMJF - SGIOF
8%
Poorly correlated
-3.85%
TEVJF - SGIOF
8%
Poorly correlated
+39.73%
More

TEVJF and

Correlation & Price change

A.I.dvisor tells us that TEVJF and IPSEF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TEVJF and IPSEF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TEVJF
1D Price
Change %
TEVJF100%
+39.73%
IPSEF - TEVJF
24%
Poorly correlated
N/A
TKPHF - TEVJF
17%
Poorly correlated
N/A
ROMJF - TEVJF
4%
Poorly correlated
-3.85%
VTRS - TEVJF
3%
Poorly correlated
-2.27%
SGIOF - TEVJF
1%
Poorly correlated
N/A
More